Thursday, November 15, 2018 3:04:45 PM
I was raising the issue about whether the device - if eventually cleared as a topical wound dressing - is saleable in a volume that would be significant financially. It seems that people are assuming that FDA clearance will translate into a market and financial success, and the financial success will be able to fund development of a more significant device. These may be unsupported assumptions. There has been no marketing or distribution plan presented, and neither the CEO nor any board memebers have successfully launched such a product in the past.
I raised the issue in an earlier post that the CEO drew compensation of $1.2 million in cash & stock compensation in 2017 for leading a prerevenue company (as reported to SEC in 10K filing), and that directors are receiving cash compensatiuon as well. This is highly unusual. However, rather than focus on likely shannigans, I tried to focus my comments on the business fundamentals. The current focus on a topical wound dressing for AC5 technology doesn't seem to lead any where positive. If the wound dressing isn't successful, then what?
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM
Maybacks Global Entertainment and Lingerie Fighting Championships Enter Into Broadcast And Revenue Sharing Agreement • AHRO • Sep 26, 2024 8:30 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM